<DOC>
	<DOC>NCT02189369</DOC>
	<brief_summary>This clinical validation study is being carried out to validate the efficacy of a test measuring the clinical application of prostaglandins present in the endometrial fluid in patients, 24 hours before the embryonic transfer. This test is capable of predicting endometrial receptivity without the need of performing a biopsy.</brief_summary>
	<brief_title>Diagnostic Test for Endometrial Receptivity 24 Hours Before Embryo Transfer</brief_title>
	<detailed_description />
	<mesh_term>Infertility</mesh_term>
	<criteria>Any IVF patient being treated for single or double embryo transfer BMI: 20 30 Normal ovarian response (7 8 ovocitos) in IVF treatment with AFC ≥ 8, (AFC = Antral Follicle Count) Elective embryo transfer Normal uterine cavity Age: ≤ 38 years old for patients with own oocytes; ≤ 50 years old for patients with donated oocytes. Patients with recurrent miscarriages ( ≥ 2 biochemical miscarriages; ≥ 2 clinical miscarriage) Patients with severe male factor ( ≥ 2*106 espermatozoides/ml).</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>